nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—ADRB3—type 2 diabetes mellitus	0.595	1	CbGaD
Bopindolol—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.124	0.415	CbGbCtD
Bopindolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0974	0.325	CbGbCtD
Bopindolol—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0779	0.26	CbGbCtD
Bopindolol—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.0101	0.639	CbGeAlD
Bopindolol—HTR1B—artery—type 2 diabetes mellitus	0.00193	0.122	CbGeAlD
Bopindolol—ADRB3—adipose tissue—type 2 diabetes mellitus	0.00136	0.0863	CbGeAlD
Bopindolol—Carvedilol—GJA1—type 2 diabetes mellitus	0.000964	0.162	CrCbGaD
Bopindolol—Carvedilol—NPPB—type 2 diabetes mellitus	0.000964	0.162	CrCbGaD
Bopindolol—Bupranolol—ADRB3—type 2 diabetes mellitus	0.000921	0.154	CrCbGaD
Bopindolol—Carvedilol—HIF1A—type 2 diabetes mellitus	0.00073	0.122	CrCbGaD
Bopindolol—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.00067	0.0425	CbGeAlD
Bopindolol—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.00063	0.04	CbGeAlD
Bopindolol—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000556	0.0353	CbGeAlD
Bopindolol—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000541	0.0343	CbGeAlD
Bopindolol—Carvedilol—ADRB3—type 2 diabetes mellitus	0.000435	0.073	CrCbGaD
Bopindolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000331	0.0555	CrCbGaD
Bopindolol—Carvedilol—VEGFA—type 2 diabetes mellitus	0.000294	0.0493	CrCbGaD
Bopindolol—Carvedilol—ADRA2A—type 2 diabetes mellitus	0.000197	0.033	CrCbGaD
Bopindolol—Mebendazole—CYP3A4—type 2 diabetes mellitus	0.000184	0.0308	CrCbGaD
Bopindolol—Propafenone—CYP1A2—type 2 diabetes mellitus	0.000152	0.0255	CrCbGaD
Bopindolol—Carvedilol—CYP2E1—type 2 diabetes mellitus	0.000144	0.0241	CrCbGaD
Bopindolol—Carvedilol—CYP1A2—type 2 diabetes mellitus	0.000137	0.0229	CrCbGaD
Bopindolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000104	0.0175	CrCbGaD
Bopindolol—Propafenone—CYP3A4—type 2 diabetes mellitus	0.000101	0.0169	CrCbGaD
Bopindolol—Carvedilol—CYP3A4—type 2 diabetes mellitus	9.06e-05	0.0152	CrCbGaD
Bopindolol—Ketoprofen—PTGS2—type 2 diabetes mellitus	7.78e-05	0.013	CrCbGaD
Bopindolol—Ketoprofen—ALB—type 2 diabetes mellitus	6.93e-05	0.0116	CrCbGaD
Bopindolol—Propranolol—CYP3A4—type 2 diabetes mellitus	6.89e-05	0.0116	CrCbGaD
Bopindolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.39e-05	0.000167	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.39e-05	0.000166	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.38e-05	0.000166	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.38e-05	0.000165	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.38e-05	0.000165	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AVP—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.36e-05	0.000163	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.36e-05	0.000163	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.35e-05	0.000162	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.35e-05	0.000161	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.35e-05	0.000161	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.34e-05	0.000161	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.34e-05	0.000161	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.34e-05	0.000161	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.34e-05	0.000161	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.32e-05	0.000159	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.32e-05	0.000158	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.32e-05	0.000158	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.32e-05	0.000158	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.3e-05	0.000156	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.3e-05	0.000156	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.3e-05	0.000156	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.29e-05	0.000154	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.28e-05	0.000154	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.28e-05	0.000154	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.28e-05	0.000153	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.27e-05	0.000152	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.27e-05	0.000152	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.26e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.26e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.26e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.25e-05	0.00015	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.25e-05	0.00015	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.25e-05	0.000149	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.24e-05	0.000149	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.24e-05	0.000148	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.23e-05	0.000148	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.23e-05	0.000147	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.23e-05	0.000147	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.23e-05	0.000147	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—INS—type 2 diabetes mellitus	1.21e-05	0.000145	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.21e-05	0.000145	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.2e-05	0.000144	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.2e-05	0.000144	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.19e-05	0.000143	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.19e-05	0.000142	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.18e-05	0.000141	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000141	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.17e-05	0.000141	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.17e-05	0.000141	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.17e-05	0.000141	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.17e-05	0.00014	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.16e-05	0.000139	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.15e-05	0.000138	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.15e-05	0.000138	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.15e-05	0.000138	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—C3—type 2 diabetes mellitus	1.14e-05	0.000136	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.13e-05	0.000135	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.13e-05	0.000135	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.12e-05	0.000134	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.11e-05	0.000134	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.1e-05	0.000132	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.09e-05	0.00013	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.08e-05	0.00013	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.08e-05	0.00013	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.08e-05	0.00013	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	1.08e-05	0.000129	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.08e-05	0.000129	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.06e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.06e-05	0.000128	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.05e-05	0.000126	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.05e-05	0.000126	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.05e-05	0.000125	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.05e-05	0.000125	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.04e-05	0.000124	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.04e-05	0.000124	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.03e-05	0.000124	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.03e-05	0.000123	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.03e-05	0.000123	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.02e-05	0.000123	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.01e-05	0.000122	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.01e-05	0.000121	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.01e-05	0.000121	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RELA—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.98e-06	0.00012	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.92e-06	0.000119	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.85e-06	0.000118	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	9.84e-06	0.000118	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.63e-06	0.000115	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	9.62e-06	0.000115	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.45e-06	0.000113	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.44e-06	0.000113	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.42e-06	0.000113	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.27e-06	0.000111	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.23e-06	0.000111	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.12e-06	0.000109	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.07e-06	0.000109	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	9.06e-06	0.000109	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	9.05e-06	0.000108	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.04e-06	0.000108	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.03e-06	0.000108	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.98e-06	0.000108	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.9e-06	0.000107	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.87e-06	0.000106	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	8.86e-06	0.000106	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.75e-06	0.000105	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.74e-06	0.000105	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.71e-06	0.000104	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	8.66e-06	0.000104	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.64e-06	0.000103	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.62e-06	0.000103	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.61e-06	0.000103	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.54e-06	0.000102	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.46e-06	0.000101	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.45e-06	0.000101	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.45e-06	0.000101	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.43e-06	0.000101	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.43e-06	0.000101	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.43e-06	0.000101	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.42e-06	0.000101	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.34e-06	9.99e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.31e-06	9.95e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.28e-06	9.92e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.28e-06	9.92e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.26e-06	9.9e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.25e-06	9.88e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.25e-06	9.88e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.24e-06	9.88e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	8.23e-06	9.86e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.15e-06	9.77e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.09e-06	9.7e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	8.07e-06	9.66e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	8.07e-06	9.66e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.97e-06	9.55e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.95e-06	9.53e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.93e-06	9.5e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.93e-06	9.5e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.87e-06	9.43e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.78e-06	9.32e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.67e-06	9.19e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.61e-06	9.11e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.52e-06	9.01e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	7.47e-06	8.95e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.36e-06	8.82e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	7.2e-06	8.63e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.2e-06	8.62e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.09e-06	8.49e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	7.05e-06	8.44e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.04e-06	8.43e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.97e-06	8.35e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.96e-06	8.34e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.93e-06	8.31e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.93e-06	8.31e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.9e-06	8.27e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.89e-06	8.26e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.82e-06	8.17e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.81e-06	8.16e-05	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.8e-06	8.14e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.78e-06	8.13e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.78e-06	8.12e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.73e-06	8.07e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.69e-06	8.02e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.66e-06	7.99e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.66e-06	7.98e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.63e-06	7.95e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.62e-06	7.93e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.47e-06	7.76e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.36e-06	7.63e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.33e-06	7.58e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.32e-06	7.57e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.32e-06	7.57e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.3e-06	7.54e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.18e-06	7.4e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.18e-06	7.4e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.17e-06	7.4e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.04e-06	7.24e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.04e-06	7.24e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.95e-06	7.12e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	5.87e-06	7.03e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.82e-06	6.97e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.71e-06	6.85e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.69e-06	6.81e-05	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.41e-06	6.49e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.36e-06	6.43e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.33e-06	6.38e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.3e-06	6.35e-05	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.3e-06	6.34e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.25e-06	6.29e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.25e-06	6.28e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.21e-06	6.25e-05	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.18e-06	6.2e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.14e-06	6.16e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.13e-06	6.15e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.1e-06	6.11e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.07e-06	6.07e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.01e-06	6.01e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.96e-06	5.94e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.92e-06	5.89e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.91e-06	5.88e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.89e-06	5.86e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.85e-06	5.81e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.81e-06	5.76e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.8e-06	5.75e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.7e-06	5.63e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.67e-06	5.6e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.57e-06	5.48e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.55e-06	5.45e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.47e-06	5.36e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.45e-06	5.33e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.35e-06	5.22e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.18e-06	5e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.1e-06	4.91e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.09e-06	4.9e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.01e-06	4.8e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4e-06	4.79e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.95e-06	4.74e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.92e-06	4.69e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.65e-06	4.37e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.15e-06	3.77e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.08e-06	3.69e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.01e-06	3.61e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.9e-06	3.48e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.84e-06	3.4e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.78e-06	3.33e-05	CbGpPWpGaD
